Have your own idea? Try our Stock Screener
Pakistani (KSE) Healthcare Sector Analysis
UpdatedApr 15, 2025
DataAggregated Company Financials
Companies15
- 7D7.4%
- 3M5.2%
- 1Y157.0%
- YTD1.8%
The Healthcare industry is up 2.2% in the last week, with GlaxoSmithKline Pakistan up 16%. This means that the industry has gained 148% over the past year. As for the next few years, earnings are expected to grow by 36% per annum.
Sector Valuation and Performance
Has the Pakistani Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Tue, 15 Apr 2025 | PK₨557.8b | PK₨304.3b | PK₨25.4b | 21x | 22x | 1.8x |
| Thu, 13 Mar 2025 | PK₨520.1b | PK₨297.7b | PK₨23.0b | 20.1x | 22.6x | 1.7x |
| Sat, 08 Feb 2025 | PK₨534.7b | PK₨287.8b | PK₨20.9b | 22.9x | 25.5x | 1.9x |
| Mon, 06 Jan 2025 | PK₨531.1b | PK₨287.8b | PK₨20.9b | 20.2x | 25.3x | 1.8x |
| Wed, 04 Dec 2024 | PK₨495.4b | PK₨287.7b | PK₨20.8b | 22x | 23.8x | 1.7x |
| Fri, 01 Nov 2024 | PK₨372.2b | PK₨285.5b | PK₨20.6b | 18.4x | 18x | 1.3x |
| Sun, 29 Sep 2024 | PK₨298.7b | PK₨281.3b | PK₨14.0b | 12.4x | 21.3x | 1.1x |
| Tue, 27 Aug 2024 | PK₨286.0b | PK₨272.9b | PK₨9.7b | 18.4x | 29.6x | 1x |
| Thu, 25 Jul 2024 | PK₨261.2b | PK₨272.9b | PK₨9.7b | 14.6x | 27x | 1x |
| Sat, 22 Jun 2024 | PK₨261.3b | PK₨272.9b | PK₨9.7b | 14.6x | 27x | 1x |
| Mon, 20 May 2024 | PK₨246.8b | PK₨263.5b | PK₨10.4b | 15.3x | 23.6x | 0.9x |
| Wed, 17 Apr 2024 | PK₨203.3b | PK₨257.0b | PK₨8.2b | 19.1x | 24.6x | 0.8x |
| Fri, 15 Mar 2024 | PK₨185.0b | PK₨251.1b | PK₨8.0b | 12.4x | 23.1x | 0.7x |
| Sun, 11 Feb 2024 | PK₨180.5b | PK₨248.2b | PK₨7.9b | 12.5x | 22.9x | 0.7x |
| Tue, 09 Jan 2024 | PK₨187.2b | PK₨248.2b | PK₨7.9b | 13.7x | 23.8x | 0.8x |
| Thu, 07 Dec 2023 | PK₨197.8b | PK₨245.1b | PK₨7.8b | 15.4x | 25.4x | 0.8x |
| Sat, 04 Nov 2023 | PK₨157.7b | PK₨241.7b | PK₨8.5b | 13.9x | 18.6x | 0.7x |
| Mon, 02 Oct 2023 | PK₨139.3b | PK₨234.6b | PK₨9.0b | 10.8x | 15.5x | 0.6x |
| Wed, 30 Aug 2023 | PK₨144.0b | PK₨232.6b | PK₨10.0b | 11.1x | 14.5x | 0.6x |
| Fri, 28 Jul 2023 | PK₨157.2b | PK₨230.3b | PK₨10.4b | 12.5x | 15.1x | 0.7x |
| Sun, 25 Jun 2023 | PK₨140.7b | PK₨230.3b | PK₨10.4b | 11.1x | 13.5x | 0.6x |
| Tue, 23 May 2023 | PK₨155.4b | PK₨223.1b | PK₨13.1b | 12.1x | 11.9x | 0.7x |
| Thu, 20 Apr 2023 | PK₨152.7b | PK₨217.4b | PK₨15.2b | 9.1x | 10x | 0.7x |
| Sat, 18 Mar 2023 | PK₨161.9b | PK₨214.7b | PK₨16.5b | 9.4x | 9.8x | 0.8x |
| Mon, 13 Feb 2023 | PK₨169.4b | PK₨211.8b | PK₨16.8b | 9.5x | 10.1x | 0.8x |
| Wed, 11 Jan 2023 | PK₨172.1b | PK₨211.8b | PK₨16.8b | 9.8x | 10.2x | 0.8x |
| Fri, 09 Dec 2022 | PK₨187.9b | PK₨210.0b | PK₨16.6b | 10.5x | 11.3x | 0.9x |
| Sun, 06 Nov 2022 | PK₨211.1b | PK₨208.4b | PK₨17.2b | 11.3x | 12.3x | 1x |
| Tue, 04 Oct 2022 | PK₨216.8b | PK₨200.0b | PK₨20.2b | 10.5x | 10.7x | 1.1x |
| Thu, 01 Sep 2022 | PK₨230.5b | PK₨189.9b | PK₨23.3b | 9.6x | 9.9x | 1.2x |
| Sat, 30 Jul 2022 | PK₨227.6b | PK₨189.9b | PK₨23.3b | 9.7x | 9.8x | 1.2x |
| Mon, 27 Jun 2022 | PK₨228.5b | PK₨188.5b | PK₨23.1b | 9.3x | 9.9x | 1.2x |
| Wed, 25 May 2022 | PK₨227.0b | PK₨184.3b | PK₨22.9b | 9.2x | 9.9x | 1.2x |
| Fri, 22 Apr 2022 | PK₨251.7b | PK₨183.4b | PK₨23.0b | 10.3x | 11x | 1.4x |
Price to Earnings Ratio
11x
Current Industry PE
- Investors are optimistic on the Pakistani Healthcare industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 21.6x which is higher than its 3-year average PE of 17.5x.
- The 3-year average PS ratio of 1.0x is lower than the industry's current PS ratio of 1.8x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have grown 3.3% per year over the last three years.
- Revenues for these companies have grown 18% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Trends
Which industries have driven the changes within the Pakistani Healthcare sector?
| PK Market | 1.88% | |
| Healthcare | 7.36% | |
| Life Sciences | 8.93% | |
| Pharma | 7.89% | |
| Healthcare Services | -1.36% | |
Industry PE
- Investors are most optimistic about the Life Sciences industry which is trading above its 3-year average PE ratio of 51.7x.
- It looks like they are confident that earnings will grow faster in the future than they have historically.
- Investors are most pessimistic about the Healthcare Services industry, although it looks like investor sentiment has improved given that it's trading above its 3-year average of 9.5x.
Forecasted Growth
- Analysts are most optimistic on the Pharma industry, expecting annual earnings growth of 36% over the next 5 years.
- However this is lower than its past earnings growth rate of 71% per year.
- In contrast, the Pharma industry is expected to see its earnings grow by 36% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| GLAXO GlaxoSmithKline Pakistan | PK₨468.40 | 16.2% +PK₨20.8b | 404.9% | PE22.8x | |
| HINOON Highnoon Laboratories | PK₨980.49 | 9.3% +PK₨4.4b | 73.1% | PE15.3x | |
| CPHL Citi Pharma | PK₨101.64 | 18.7% +PK₨3.7b | 312.8% | PE28.3x | |
| AGP AGP | PK₨200.24 | 6.0% +PK₨3.2b | 163.4% | PE21x | |
| ABOT Abbott Laboratories (Pakistan) | PK₨1.07k | 1.6% +PK₨1.7b | 102.7% | PE20.1x |